- Home
- NXTT vs LIPO Comparison
NXTT vs LIPO Comparison
Compare NXTT & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- LIPO
- Stock Information
- Founded
- NXTT 2019
- LIPO 2005
- Country
- NXTT China
- LIPO United States
- Employees
- NXTT N/A
- LIPO N/A
- Industry
- NXTT
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- NXTT
- LIPO Health Care
- Exchange
- NXTT NYSE
- LIPO Nasdaq
- Market Cap
- NXTT 3.5M
- LIPO 3.1M
- IPO Year
- NXTT N/A
- LIPO 2022
- Fundamental
- Price
- NXTT $0.30
- LIPO $2.57
- Analyst Decision
- NXTT
- LIPO Strong Buy
- Analyst Count
- NXTT 0
- LIPO 1
- Target Price
- NXTT N/A
- LIPO $16.00
- AVG Volume (30 Days)
- NXTT 444.4K
- LIPO 45.5K
- Earning Date
- NXTT 05-19-2025
- LIPO 05-08-2025
- Dividend Yield
- NXTT N/A
- LIPO N/A
- EPS Growth
- NXTT N/A
- LIPO N/A
- EPS
- NXTT 3.70
- LIPO N/A
- Revenue
- NXTT $1,800,000.00
- LIPO $536,357.00
- Revenue This Year
- NXTT N/A
- LIPO N/A
- Revenue Next Year
- NXTT N/A
- LIPO N/A
- P/E Ratio
- NXTT $0.08
- LIPO N/A
- Revenue Growth
- NXTT N/A
- LIPO 19.29
- 52 Week Low
- NXTT $0.28
- LIPO $2.02
- 52 Week High
- NXTT $6.66
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- NXTT 27.46
- LIPO 48.43
- Support Level
- NXTT $0.28
- LIPO $2.13
- Resistance Level
- NXTT $0.32
- LIPO $2.74
- Average True Range (ATR)
- NXTT 0.04
- LIPO 0.21
- MACD
- NXTT 0.04
- LIPO 0.05
- Stochastic Oscillator
- NXTT 20.51
- LIPO 76.06
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.